Delivery Order N6264523D5005-N0018924FZ059
- Not listed
- This is a firm fixed price purchase order contract awarded by the U.S. Department of the Navy Bureau of Medicine and Surgery to Illumina, Inc., a manufacturer of genetic sequencing equipment and reagents. The $102,361.40 contract is for the provision of NextSeq, NovaSeq, MiSeq, and iSeq sequencing systems, along with accompanying reagents, consumables, sample prep kits, sequencing chips, support plans, maintenance services, and bioinformatics products. This contract is not set aside for any...
- This federal contract award to Illumina, Inc. is for the provision of BIOLOGICAL AND REAGENT KITS - NOVASEQ REAGENT KITS for the National Institute on Aging, a civilian agency. The $24,919.37 firm fixed price delivery order contract has a period of performance through September 20, 2024 and does not utilize any set-aside designation. Illumina is a manufacturer and provider of sequencing and array-based solutions for genetic and genomic analysis, and has previously provided a range of...
- The U.S. Navy's Bureau of Medicine and Surgery awarded Illumina, Inc. a fixed-price delivery order valued at $82,029.96 for NovaSeq 6000 S4 Reagent Kit V1.5, with an ultimate completion date of June 16, 2025. The contract, awarded on June 6, 2025, involves fixed-price pricing with economic price adjustment provisions and carries no set-aside designation. Performance will take place in Frederick, Maryland, where the reagent kits will support the Navy's genomic sequencing and analysis...
- This firm fixed-price purchase order contract was awarded by the Department of the Navy's Bureau of Medicine and Surgery to Illumina, Inc., a manufacturer of sequencing and genomic analysis solutions. The contract, valued at $98,450.40, is to provide the agency with TruSeq Nano DNA Kits and MiSeq Reagent Kit V2 for genomic sequencing and analysis. This appears to be a delivery order under a larger Indefinite Delivery Contract worth up to $3.3 million that supports the Navy's nucleic acid...
- This federal contract award to Illumina, Inc. is for the delivery of NovaSeq X Series 100 cycle reagent kits. The $10,342.85 firm fixed price delivery order was placed by the National Human Genome Research Institute, a civilian agency under the National Institutes of Health (NIH). The award has an ultimate completion date of March 31, 2025 and does not utilize any set-aside designation. Through prior prime contract awards, Illumina has provided a range of genomic sequencing instruments,...
- This is a firm fixed price purchase order awarded by the Bureau of Medicine and Surgery, a defense agency, to Illumina, Inc., a manufacturer of genetic sequencing systems and reagents. The contract is for the first shipment of MiSeq reagents, with a ceiling value of $130,556.94 and a completion date of September 30, 2024. Illumina has previously received prime contracts and subcontracts from various civilian and defense agencies to provide sequencing instruments, reagents, and associated...
- This federal contract award was issued by the National Institutes of Health (NIH) to Illumina, Inc., a manufacturer of sequencing and array-based solutions for genetic and genomic analysis. The $122,667.76 firm fixed price delivery order is for the provision of supplies, including various NextSeq, NovaSeq, MiSeq, and iSeq sequencing systems, reagents, consumables, and support services. The award does not have a set-aside designation. Illumina has previously received multiple federal contracts...
- This is a delivery order awarded by the Department of the Navy Bureau of Medicine and Surgery (BUMED) to Illumina, Inc., a manufacturer of genomic sequencing systems and reagents. The $67,493.84 fixed-price contract is for the provision of medical laboratory supplies, specifically reagents and controls for Illumina's MiSeq, iSeq, NextSeq, and NovaSeq6000 sequencing platforms. These instruments are used by the Naval Medical Research Center's Biological Defense Research Directorate to characterize...
- This is a firm fixed-price delivery order awarded by the National Institute on Aging, a civilian agency within the U.S. Department of Health and Human Services, to Illumina, Inc., a manufacturer of genetic sequencing systems and reagents. The $872,996.22 award is for the provision of Illumina reagent kits to support genomic analysis and sequencing work. This order falls under a larger Indefinite Delivery Contract that Illumina holds with the Department of the Navy's Bureau of Medicine and...
- This federal contract award, valued at $161,610.94, was issued by the National Institute of Environmental Health Sciences (NIEHS), a civilian agency, to Illumina, Inc. as the prime contractor. The award is for the delivery of various Illumina sequencing systems, reagents, and related services to support genomic sequencing and analysis. This appears to be a delivery order under a larger Indefinite Delivery Contract that Illumina holds with the Department of the Navy Bureau of Medicine and...
- N6264523D5005Indefinite Delivery Contract
- N6264523D5005-N0018924FZ059Delivery Order
This federal contract award to Illumina, Inc. is for the delivery of NOVASEQ 6000 S4 REAGENT KIT V1.5 with a ceiling value of $103,216.74. The contract is a firm fixed price delivery order, awarded by the U.S. Navy's Bureau of Medicine and Surgery, a defense agency. The contract has no set-aside designation. Illumina, Inc. is a manufacturer and provider of sequencing and array-based solutions for genetic and genomic analysis, and has a history of providing sequencing systems, reagents, and other genomics products and services to various federal agencies, including the National Institutes of Health (NIH), Centers for Disease Control and Prevention (CDC), Department of Agriculture (USDA), and Department of Veterans Affairs (VA). This specific award is made under an Indefinite Delivery Contract worth up to $3.3 million, intended to support nucleic acid sequencing needs at the Naval Medical Research Center's Biological Defense Research Directorate for characterizing biological threats. The contract has an ultimate completion date of May 2, 2024.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| P00001 | Other Administrative Action | $3.6k | 4/30/24 | |
| Not listed | Not listed | $99.7k | 4/24/24 |